PREP inhibition has been shown to have significant potential in clearing aggregated proteins such as α-synuclein and being able to reduce the level of reactive oxygen species (ROS) and inflammation [7,18], which makes PREP inhibition an interesting therapeutic approach for AMD. Here, PREP is linked to age-related macular degeneration.